Open Access
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
Zhu-Wei Miao, Zhi Wang, Si-Li Zheng, Shu-Na Wang, Chao-Yu Miao
DOI: 10.1136/svn-2023-002883 Published 5 November 2024
Zhu-Wei Miao
Department of Pharmacology, Second Military Medical University/ Naval Medical University, Shanghai, China
Zhi Wang
Department of Pharmacology, Second Military Medical University/ Naval Medical University, Shanghai, China
Si-Li Zheng
Department of Pharmacology, Second Military Medical University/ Naval Medical University, Shanghai, China
Shu-Na Wang
Department of Pharmacology, Second Military Medical University/ Naval Medical University, Shanghai, China
Chao-Yu Miao
Department of Pharmacology, Second Military Medical University/ Naval Medical University, Shanghai, China

Submit a Response to This Article
No eLetters have been published for this article.
Anti-stroke biologics: from recombinant proteins to stem cells and organoids
Zhu-Wei Miao, Zhi Wang, Si-Li Zheng, Shu-Na Wang, Chao-Yu Miao
Stroke and Vascular Neurology Oct 2024, 9 (5) 467-480; DOI: 10.1136/svn-2023-002883